Prevalence of Lipoprotein(a) Measurements in Patients with or at Risk of Cardiovascular Disease
Elevated lipoprotein(a) [Lp(a)] is an atherogenic, cholesterol-containing, genetically-determined, independent risk factor for ischemic cardiovascular disease outcomes. In clinical settings, elevated serum Lp(a) predicts increased myocardial infarction, stroke, peripheral arterial disease, and aortic valve stenosis risk. Knowledge of a patient's Lp(a) may modify management, including a lower low-density lipoprotein cholesterol (LDL-C) goal and consideration of using a PCSK9 inhibitor.
Source: Journal of Clinical Lipidology - Category: Lipidology Authors: Bhavana Upadhyaya, Robert C. Block, Ying Wang, Jeffrey T. Bruckel Tags: Epidemiology of Cardiovascular Disease Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Epidemiology | Genetics | Heart | Heart Attack | Ischemic Stroke | Lipidology | Stroke